{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-028985","form_type":"8-K","ticker":"ANGO","cik":"0001275187","company_name":"ANGIODYNAMICS INC","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.243053+00:00","generated_at":"2026-06-14T04:45:00.063955+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"AngioDynamics sells dialysis product portfolio and BioSentry to Merit Medical for $100M cash","bullets":["Deal includes DuraFlow, DuraMax, Evenmore, Schon XL, Trio-CT, Vaxel Plus catheters and BioSentry biopsy product.","Divested portfolio contributed approximately $32M in sales in FY2023.","Net proceeds will be used to eliminate existing debt and fund strategic growth investments.","Transaction is dilutive to adjusted EPS and slightly dilutive to corporate gross margins.","Preliminary FY2023 net sales in the range of $338M to $339M; full results due early July."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-028985","json":"https://secwatch.observer/filing/0001140361-23-028985.json","markdown":"https://secwatch.observer/filing/0001140361-23-028985.md","text":"https://secwatch.observer/filing/0001140361-23-028985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123028985/0001140361-23-028985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123028985/brhc20054227_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T04:45:00.063955+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}